Previous Article | Next Article 
Journal of Clinical Microbiology, September 2001, p. 3092-3098, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3092-3098.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
Enhancing the Specificity of the COBAS AMPLICOR CT/NG Test for
Neisseria gonorrhoeae by Retesting Specimens with
Equivocal Results
Barbara
Van Der Pol,1
David H.
Martin,2,3
Julius
Schachter,4
Thomas C.
Quinn,5,6
Charlotte A.
Gaydos,6
Robert B.
Jones,1
Kimberly
Crotchfelt,6
Jeanne
Moncada,4
D.
Jungkind,7
Buffy
Turner,8
Cynthia
Peyton,8
James F.
Kelly,9
Judith B.
Weiss,9 and
Maurice
Rosenstraus9,*
Indiana University School of Medicine,
Indianapolis, Indiana1; Louisiana State
University2 and City of New Orleans'
Delgado Clinic,3 New Orleans, Louisiana;
University of California
San Francisco, San
Francisco,4 and Roche Molecular Systems,
Pleasanton,9 California; National
Institute of Allergy and Infectious Diseases, National Institutes
of Health, Bethesda,5 and Johns Hopkins
University, Baltimore,6 Maryland;
Thomas Jefferson University Hospital, Pittsburgh,
Pennsylvania7; and University of
Texas Medical Branch, Galveston, Texas8
Received 7 December 2000/Returned for modification 28 April
2001/Accepted 20 June 2001
The COBAS AMPLICOR CT/NG test for Neisseria gonorrhoeae
cross-reacts with certain strains of nonpathogenic
Neisseria species. In some strains, the target sequence is
identical to that of N. gonorrhoeae, whereas other strains
have a small number of mismatches within the regions recognized by the
primers or probe used in the COBAS AMPLICOR NG test. These
cross-reactive strains are occasionally present in urogenital
specimens, causing false-positive results in the COBAS AMPLICOR NG
test. Analysis of the data generated in a large multicenter clinical
trial showed that 2.9% of the specimens gave signals between
A660s of 0.2 and 3.5 but that one-half of these
equivocal specimens did not contain N. gonorrhoeae. Most of
these equivocal specimens were correctly classified as true positive or
true negative by retesting in duplicate and defining a PCR-positive
result as two of three results with an A660 of
2.0. If specimens had been classified as positive or negative based
on a single test result using a cutoff of an
A660 of 0.2, specificity would have ranged from
96.2 to 98.9% depending on specimen type, sex, and presence of
symptoms. By employing the equivocal zone-retesting algorithm,
specificity increased to 98.6 to 99.9% with little effect (0.1 to
4.9% decrease) on sensitivity in most specimen types, enabling the
test to achieve a positive predictive value of at least 90% in
populations with a prevalence of 4% or higher. In
lower-prevalence populations, the test could be used to screen for
presumptive infections that would have to be confirmed by an
independent test.
*
Corresponding author. Mailing address: Roche Molecular
Systems, 1080 U.S. Highway 202 South, Somerville, NJ 08876. Phone: (908) 253-7463. Fax: (908) 253-3318. E-mail:
maurice.rosenstraus{at}roche.com.
Journal of Clinical Microbiology, September 2001, p. 3092-3098, Vol. 39, No. 9
0095-1137/01/$04.00+0 DOI: 10.1128/JCM.39.9.3092-3098.2001
Copyright © 2001, American Society for Microbiology. All rights reserved.
This article has been cited by other articles:
-
Moncada, J., Schachter, J., Liska, S., Shayevich, C., Klausner, J. D.
(2009). Evaluation of Self-Collected Glans and Rectal Swabs from Men Who Have Sex with Men for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae by Use of Nucleic Acid Amplification Tests. J. Clin. Microbiol.
47: 1657-1662
[Abstract]
[Full Text]
-
Bachmann, L. H., Johnson, R. E., Cheng, H., Markowitz, L. E., Papp, J. R., Hook, E. W. III
(2009). Nucleic Acid Amplification Tests for Diagnosis of Neisseria gonorrhoeae Oropharyngeal Infections. J. Clin. Microbiol.
47: 902-907
[Abstract]
[Full Text]
-
Moncada, J., Donegan, E., Schachter, J.
(2008). Evaluation of CDC-Recommended Approaches for Confirmatory Testing of Positive Neisseria gonorrhoeae Nucleic Acid Amplification Test Results. J. Clin. Microbiol.
46: 1614-1619
[Abstract]
[Full Text]
-
Peter-Getzlaff, S., Luethy, J., Springer, B., Kaul, K. L., Mangold, K. A.
(2007). Diagnostic Value of Molecular Confirmation Assays for Neisseria gonorrhoeae. J. Clin. Microbiol.
45: 3856-3858
[Full Text]
-
Mangold, K. A., Regner, M., Tajuddin, M., Tajuddin, A. M., Jennings, L., Du, H., Kaul, K. L.
(2007). Neisseria Species Identification Assay for the Confirmation of Neisseria gonorrhoeae-Positive Results of the COBAS Amplicor PCR. J. Clin. Microbiol.
45: 1403-1409
[Abstract]
[Full Text]
-
Alary, M, Gbenafa-Agossa, C, Aina, G, Ndour, M, Labbe, A C, Fortin, D, Steele, M, Peeling, R W
(2006). Evaluation of a rapid point-of-care test for the detection of gonococcal infection among female sex workers in Benin. Sex. Transm. Infect.
82: v29-v32
[Abstract]
[Full Text]
-
Lowe, P., O'Loughlin, P., Evans, K., White, M., Bartley, P. B., Vohra, R.
(2006). Comparison of the Gen-Probe APTIMA Combo 2 Assay to the AMPLICOR CT/NG Assay for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae in Urine Samples from Australian Men and Women.. J. Clin. Microbiol.
44: 2619-2621
[Abstract]
[Full Text]
-
Boel, C. H. E., van Herk, C. M. C., Berretty, P. J. M., Onland, G. H. W., van den Brule, A. J. C.
(2005). Evaluation of Conventional and Real-Time PCR Assays Using Two Targets for Confirmation of Results of the COBAS AMPLICOR Chlamydia trachomatis/Neisseria gonorrhoeae Test for Detection of Neisseria gonorrhoeae in Clinical Samples. J. Clin. Microbiol.
43: 2231-2235
[Abstract]
[Full Text]
-
Luijt, D. S., Bos, P. A. J., van Zwet, A. A., van Voorst Vader, P. C., Schirm, J.
(2005). Comparison of COBAS AMPLICOR Neisseria gonorrhoeae PCR, Including Confirmation with N. gonorrhoeae-Specific 16S rRNA PCR, with Traditional Culture. J. Clin. Microbiol.
43: 1445-1447
[Abstract]
[Full Text]
-
Lynn, F., Hobbs, M. M., Zenilman, J. M., Behets, F. M. T. F., Van Damme, K., Rasamindrakotroka, A., Bash, M. C.
(2005). Genetic Typing of the Porin Protein of Neisseria gonorrhoeae from Clinical Noncultured Samples for Strain Characterization and Identification of Mixed Gonococcal Infections. J. Clin. Microbiol.
43: 368-375
[Abstract]
[Full Text]
-
Boyadzhyan, B., Yashina, T., Yatabe, J. H., Patnaik, M., Hill, C. S.
(2004). Comparison of the APTIMA CT and GC Assays with the APTIMA Combo 2 Assay, the Abbott LCx Assay, and Direct Fluorescent-Antibody and Culture Assays for Detection of Chlamydia trachomatis and Neisseria gonorrhoeae. J. Clin. Microbiol.
42: 3089-3093
[Abstract]
[Full Text]
-
Tabrizi, S N, Chen, S, Cohenford, M A, Lentrichia, B B, Coffman, E, Shultz, T, Tapsall, J W, Garland, S M
(2004). Evaluation of real time polymerase chain reaction assays for confirmation of Neisseria gonorrhoeae in clinical samples tested positive in the Roche Cobas Amplicor assay. Sex. Transm. Infect.
80: 68-71
[Abstract]
[Full Text]
-
Diemert, D. J., Libman, M. D., Lebel, P.
(2002). Confirmation by 16S rRNA PCR of the COBAS AMPLICOR CT/NG Test for Diagnosis of Neisseria gonorrhoeae Infection in a Low-Prevalence Population. J. Clin. Microbiol.
40: 4056-4059
[Abstract]
[Full Text]